New study tests nutritional supplement to tame chemo side effects

NCT ID NCT07590622

Not yet recruiting Symptom relief Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special nutritional supplement (LH BLU) can reduce serious side effects in people with advanced gastrointestinal cancers who are starting chemotherapy. About 88 participants will either receive the supplement plus nutritional counseling or just counseling alone. The main goal is to see if the supplement lowers the chance of severe side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LH BLU (a special nutritional supplement with extra nutrients like glutamine, vitamin D, zinc, and selenium)
What this could lead to: If it works, this could point toward a way to reduce severe side effects from chemotherapy in advanced gastrointestinal cancer patients.
What could go wrong: This is a small, early-stage trial with only 88 participants, so results may not apply to everyone. The supplement may not reduce side effects more than standard nutritional counseling.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

digestive system cancer digestive system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROINTESTINAL CANCER

More trials for these conditions

Other studies related to the condition(s) this trial covers.